Skip to content
10-Q

Quarterly Report

PARATEK PHARMACEUTICALS, INC.

0001178711-22-000011

← back to feed
Filed
Aug 3, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2022 · Jul 31, 2022 54.86M sh
Long Term Debt Q2 2022 · Jun 30, 2022 $257.15M
Long Term Debt Q2 2022 · Dec 31, 2021 $254.43M
Current Liabilities Q2 2022 · Jun 30, 2022 $30.1M
Current Liabilities Q2 2022 · Dec 31, 2021 $31.3M
Total Liabilities Q2 2022 · Jun 30, 2022 $313.06M
Total Liabilities Q2 2022 · Dec 31, 2021 $311.66M
Current Assets Q2 2022 · Jun 30, 2022 $127.77M
Current Assets Q2 2022 · Dec 31, 2021 $152.1M
Total Assets Q2 2022 · Jun 30, 2022 $163.7M
Total Assets Q2 2022 · Dec 31, 2021 $183.87M
Cash And Equivalents Q2 2022 · Dec 31, 2021 $80.37M
Cash And Equivalents Q2 2022 · Jun 30, 2021 $75.3M
Shares Diluted Q2 2022 · Jun 30, 2021 48.95M sh
Shares Diluted Q2 2022 · Jun 30, 2021 46.89M sh
Operating Cash Flow Q2 2022 · Jun 30, 2021 −$54.72M
Stockholders Equity Q2 2022 · Jun 30, 2021 −$99.29M
Stockholders Equity Q2 2022 · Mar 31, 2021 −$119.01M
Stockholders Equity Q2 2022 · Dec 31, 2020 −$102.26M
Eps Diluted Q2 2022 · Jun 30, 2021 $0.20
Eps Diluted Q2 2022 · Jun 30, 2021 −$0.18
Eps Basic Q2 2022 · Jun 30, 2021 $0.20
Eps Basic Q2 2022 · Jun 30, 2021 −$0.18
Sga Expense Q2 2022 · Jun 30, 2021 $27.11M
Sga Expense Q2 2022 · Jun 30, 2021 $49.47M
Net Income Q2 2022 · Jun 30, 2021 $9.72M
Net Income Q2 2022 · Jun 30, 2021 −$8.63M
Net Income Q2 2022 · Mar 31, 2021 −$18.35M
Operating Income Q2 2022 · Jun 30, 2021 $14.09M
Operating Income Q2 2022 · Jun 30, 2021 −$132K
Cost Of Revenue Q2 2022 · Jun 30, 2021 $9.78M
Cost Of Revenue Q2 2022 · Jun 30, 2021 $12.53M
Revenue Q2 2022 · Jun 30, 2021 $57.49M
Revenue Q2 2022 · Jun 30, 2021 $73.92M